BRCA2 and cancer: Recently, Wang et al.15, with the same approach, proposed that having a germline heterozygous BRCA2 mutation predisposes to pediatric or adolescent non–Hodgkin lymphoma, by showing an overrepresentation of the BRCA2 mutations in the target group compared to a control population without cancer (odds ratio, 3.3; 95% CI, 1.7–5.8)15.